SC 13G: Kiniksa Pharmaceuticals International, plc
Ticker: KNSA · Form: SC 13G · Filed: Oct 21, 2024 · CIK: 1730430
| Field | Detail |
|---|---|
| Company | Kiniksa Pharmaceuticals International, PLC (KNSA) |
| Form Type | SC 13G |
| Filed Date | Oct 21, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Kiniksa Pharmaceuticals International, plc.
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Kiniksa Pharmaceuticals International, PLC (ticker: KNSA) to the SEC on Oct 21, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on October 21, 2024 regarding Kiniksa Pharmaceuticals International, plc (KNSA).